Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCT.
Najima Y, Sadato D, Harada Y, Oboki K, Hirama C, Toya T, Doki N, Haraguchi K, Yoshifuji K, Akiyama M, Inamoto K, Igarashi A, Kobayashi T, Kakihana K, Okuyama Y, Sakamaki H, Harada H, Ohashi K. Najima Y, et al. Among authors: yoshifuji k. Bone Marrow Transplant. 2021 Feb;56(2):334-346. doi: 10.1038/s41409-020-01016-9. Epub 2020 Aug 5. Bone Marrow Transplant. 2021. PMID: 32760007
Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis.
Tanaka K, Ichikawa A, Umezawa N, Yamamoto K, Yoshifuji K, Okada K, Nogami A, Umezawa Y, Nagao T, Sakashita C, Mori T, Tohda S, Koike R, Yasuda S, Yamamoto M. Tanaka K, et al. Among authors: yoshifuji k. Cancer Sci. 2023 Sep;114(9):3719-3727. doi: 10.1111/cas.15894. Epub 2023 Jun 26. Cancer Sci. 2023. PMID: 37365854 Free PMC article.
Geriatric nutritional risk index (GNRI) just before allogeneic hematopoietic stem cell transplantation predicts transplant outcomes in patients older than 50 years with acute myeloid leukemia in complete remission.
Konishi T, Doki N, Kishida Y, Nagata A, Yamada Y, Kaito S, Kurosawa S, Yoshifuji K, Shirane S, Uchida T, Inamoto K, Toya T, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Konishi T, et al. Among authors: yoshifuji k. Ann Hematol. 2019 Jul;98(7):1799-1801. doi: 10.1007/s00277-019-03668-0. Epub 2019 Mar 21. Ann Hematol. 2019. PMID: 30899981 No abstract available.
Successful hematopoietic stem-cell mobilization with plerixafor plus granulocyte-colony stimulating factor in multiple myeloma patients treated with pomalidomide.
Yoshifuji K, Toya T, Adachi H, Fujita M, Wada A, Konuma R, Kishida Y, Konishi T, Nagata A, Yamada Y, Kaito S, Kumagai T, Inamoto K, Akiyama M, Igarashi A, Najima Y, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Yoshifuji K, et al. Int J Hematol. 2019 Jul;110(1):115-118. doi: 10.1007/s12185-019-02622-0. Epub 2019 Apr 13. Int J Hematol. 2019. PMID: 30989487
[Tyrosine kinase inhibitor maintenance therapy following allogenic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].
Uchida T, Doki N, Kishida Y, Nagata A, Yamada Y, Konishi T, Kaito S, Kurosawa S, Yoshifuji K, Shirane S, Inamoto K, Toya T, Igarashi A, Najima Y, Muto H, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Uchida T, et al. Among authors: yoshifuji k. Rinsho Ketsueki. 2020;61(1):11-19. doi: 10.11406/rinketsu.61.11. Rinsho Ketsueki. 2020. PMID: 32023596 Japanese.
Bone turnover markers as an aid to monitor osteoporosis following allogeneic hematopoietic stem cell transplantation.
Kurosawa S, Doki N, Senoo Y, Kishida Y, Nagata A, Yamada Y, Konishi T, Kaito S, Yoshifuji K, Matsuyama N, Shirane S, Uchida T, Inamoto K, Toya T, Igarashi A, Najima Y, Muto H, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Kurosawa S, et al. Among authors: yoshifuji k. Ann Hematol. 2020 Aug;99(8):1873-1882. doi: 10.1007/s00277-020-04090-7. Epub 2020 May 25. Ann Hematol. 2020. PMID: 32451708 Clinical Trial.
60 results